Cresco Labs (CRLBF) Total Liabilities (2019 - 2026)
Cresco Labs filings provide 8 years of Total Liabilities readings, the most recent being $954.6 million for Q1 2026.
- On a quarterly basis, Total Liabilities fell 3.43% to $954.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $954.6 million, a 3.43% decrease, with the full-year FY2025 number at $944.8 million, down 2.31% from a year prior.
- Total Liabilities hit $954.6 million in Q1 2026 for Cresco Labs, up from $944.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $1.0 billion in Q1 2022 to a low of $917.4 million in Q2 2022.
- Median Total Liabilities over the past 5 years was $973.3 million (2023), compared with a mean of $970.2 million.
- Biggest five-year swings in Total Liabilities: skyrocketed 46.56% in 2022 and later decreased 7.61% in 2025.
- Cresco Labs' Total Liabilities stood at $996.0 million in 2022, then decreased by 6.59% to $930.4 million in 2023, then rose by 3.95% to $967.2 million in 2024, then decreased by 2.31% to $944.8 million in 2025, then grew by 1.04% to $954.6 million in 2026.
- The last three reported values for Total Liabilities were $954.6 million (Q1 2026), $944.8 million (Q4 2025), and $940.2 million (Q3 2025) per Business Quant data.